Enveric Biosciences, Inc.
USD1.38
+0.01 (+0.36%)
CEO
Joseph Edward Tucker
IPO Date
2015-05-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.38
Prev. Close
$1.38
Day Low
$1.33
Day High
$1.40
52W Low
$1.26
52W High
$17.64
Market Cap
$0.00B
Volume
0.06M
| -0.3 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -0.9% | -0.4% | 0.00 | 1.53 | -2850.4 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -126.1% | -94.6% | 0.00 | 4.61 | -4.3 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -219.6% | -183.3% | 0.01 | 8.51 | -6.7 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -201.0% | -167.6% | 0.00 | 3.35 | -53.6 |
| 31 Dec 2019 | FY | 20.4% | -14.0% | -52.8% | -22.4% | 0.46 | 0.53 | -32.0 |
| 31 Dec 2018 | FY | 20.9% | -39.3% | -157.1% | -57.0% | 0.48 | 0.68 | -3.7 |
| 31 Dec 2017 | FY | 21.1% | -18.7% | -46.7% | -17.4% | 0.37 | 0.48 | -76.9 |
| 31 Dec 2016 | FY | 18.1% | -7.7% | -23.8% | -7.0% | 0.43 | 0.79 | -459.3 |
| -0.4 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -54.2% | -43.0% | 0.00 | 4.60 | -0.3 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -115.3% | -71.0% | 0.05 | 2.43 | -0.3 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -55.8% | -42.8% | 0.00 | 4.08 | -0.0 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -198.1% | -102.3% | 0.00 | 1.84 | -0.2 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -52.7% | -43.5% | 0.00 | 5.17 | -0.5 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -34.8% | -31.1% | 0.00 | 8.55 | -2.7 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -37.9% | -27.8% | 0.00 | 3.48 | -5.4 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -175.6% | -79.9% | 0.00 | 1.53 | -2.5 |